HCFA TAC Should Be Modeled After FDA Advisory Panels, MDMA Says
This article was originally published in The Gray Sheet
Executive Summary
The Health Care Financing Administration should adopt the FDA advisory committee structure in reconstituting or replacing the Technology Advisory Committee, the Medical Device Manufacturers Association is proposing to HCFA Administrator Nancy-Ann DeParle.
You may also be interested in...
HCFA To Revisit "Date Of Service" Definition In Negotiated Lab Claims Rule
Members of the Negotiated Rulemaking Committee on Clinical Diagnostic Laboratory Tests are recommending that the "date of service" for Medicare claims be "the date the tested specimen was collected," but they admit that further discussion of the issue is warranted.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.